APA (7th ed.) Citation

Judson, I., & Hohenberger, P. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: A randomised controlled phase 3 trial. The lancet. Oncology, 15(4), . https://doi.org/10.1016/S1470-2045(14)70063-4

Chicago Style (17th ed.) Citation

Judson, Ian, and Peter Hohenberger. "Doxorubicin Alone Versus Intensified Doxorubicin Plus Ifosfamide for First-line Treatment of Advanced or Metastatic Soft-tissue Sarcoma: A Randomised Controlled Phase 3 Trial." The Lancet. Oncology 15, no. 4 (2014). https://doi.org/10.1016/S1470-2045(14)70063-4.

MLA (9th ed.) Citation

Judson, Ian, and Peter Hohenberger. "Doxorubicin Alone Versus Intensified Doxorubicin Plus Ifosfamide for First-line Treatment of Advanced or Metastatic Soft-tissue Sarcoma: A Randomised Controlled Phase 3 Trial." The Lancet. Oncology, vol. 15, no. 4, 2014, https://doi.org/10.1016/S1470-2045(14)70063-4.